PortfoliosLab logoPortfoliosLab logo
MAVF vs. SMRI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MAVF vs. SMRI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Matrix Advisors Value ETF (MAVF) and Bushido Capital US Equity ETF (SMRI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MAVF achieves a 13.40% return, which is significantly lower than SMRI's 23.03% return.


MAVF

1D
1.34%
1M
1.14%
6M
8.67%
YTD
13.40%
1Y
27.51%
3Y*
5Y*
10Y*
ALL TIME*
22.89%

SMRI

1D
0.38%
1M
5.51%
6M
23.61%
YTD
23.03%
1Y
40.59%
3Y*
5Y*
10Y*
ALL TIME*
22.95%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$33.66K$41.27K$52.86K
$770.42K$508.81K$403.01K

MAVF vs. SMRI - Yearly Performance Comparison


2026 (YTD)2025
MAVF
Matrix Advisors Value ETF
13.40%18.40%
SMRI
Bushido Capital US Equity ETF
23.03%13.59%

Correlation

The correlation between MAVF and SMRI is 0.60, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.60

Correlation (All Time)
Calculated using the full available price history since Feb 24, 2025

0.67

The correlation between MAVF and SMRI has been stable across timeframes, ranging from 0.60 to 0.67 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MAVF vs. SMRI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MAVF
MAVF Risk / Return Rank: 7171
Overall Rank
MAVF Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
MAVF Sortino Ratio Rank: 7373
Sortino Ratio Rank
MAVF Omega Ratio Rank: 7171
Omega Ratio Rank
MAVF Calmar Ratio Rank: 6565
Calmar Ratio Rank
MAVF Martin Ratio Rank: 7373
Martin Ratio Rank

SMRI
SMRI Risk / Return Rank: 9494
Overall Rank
SMRI Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
SMRI Sortino Ratio Rank: 9494
Sortino Ratio Rank
SMRI Omega Ratio Rank: 9292
Omega Ratio Rank
SMRI Calmar Ratio Rank: 9595
Calmar Ratio Rank
SMRI Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MAVF vs. SMRI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Matrix Advisors Value ETF (MAVF) and Bushido Capital US Equity ETF (SMRI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MAVFSMRIDifference
Sharpe ratioReturn per unit of total volatility

-0.92

Sortino ratioReturn per unit of downside risk

-1.27

Omega ratioGain probability vs. loss probability

1.30

1.47

-0.17

Calmar ratioReturn relative to maximum drawdown

2.32

5.75

-3.44

Martin ratioReturn relative to average drawdown

9.18

16.88

-7.70

MAVF vs. SMRI - Sharpe Ratio Comparison

The current MAVF Sharpe Ratio is 1.72, which is lower than the SMRI Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of MAVF and SMRI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MAVF vs. SMRI - Drawdown Comparison

The maximum MAVF drawdown since its inception was -17.13%, smaller than the maximum SMRI drawdown of -18.45%. Use the drawdown chart below to compare losses from any high point for MAVF and SMRI.


Loading charts...

Drawdown Indicators


MAVFSMRIDifference

Max Drawdown

Largest peak-to-trough decline

-17.13%

-18.45%

+1.32%

Max Drawdown (1Y)

Largest decline over 1 year

-10.94%

-6.80%

-4.14%

Current Drawdown

Current decline from peak

-1.00%

-0.51%

-0.49%

Average Drawdown

Average peak-to-trough decline

-2.47%

-2.72%

+0.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.76%

2.32%

+0.44%

Volatility

MAVF vs. SMRI - Volatility Comparison

Matrix Advisors Value ETF (MAVF) has a higher volatility of 4.32% compared to Bushido Capital US Equity ETF (SMRI) at 3.61%. This indicates that MAVF's price experiences larger fluctuations and is considered to be riskier than SMRI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MAVFSMRIDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.32%

3.61%

+0.71%

Volatility (6M)

Calculated over the trailing 6-month period

11.56%

11.80%

-0.24%

Volatility (1Y)

Calculated over the trailing 1-year period

14.75%

15.09%

-0.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.83%

15.84%

+2.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.83%

15.84%

+2.99%

MAVF vs. SMRI - Expense Ratio Comparison

MAVF has a 0.75% expense ratio, which is higher than SMRI's 0.71% expense ratio.


Dividends

MAVF vs. SMRI - Dividend Comparison

MAVF's dividend yield for the trailing twelve months is around 0.37%, less than SMRI's 0.86% yield.


PositionTTM202520242023
MAVF
Matrix Advisors Value ETF
0.37%0.42%0.00%0.00%
SMRI
Bushido Capital US Equity ETF
0.86%1.32%0.98%0.45%

Frequently Asked Questions


MAVF and SMRI have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MAVF has higher volatility (4.32%) compared to SMRI (3.61%). In terms of maximum drawdown, MAVF dropped -17.13% vs SMRI's -18.45%.

On 1-year performance, SMRI leads with 40.59% vs 27.51% for MAVF. On fees, SMRI is cheaper at 0.71% per year. On volatility, SMRI has been the lower-risk option at 3.61%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, SMRI has performed better with a 40.59% return vs 27.51%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SMRI is cheaper with a 0.71% expense ratio, compared with 0.75% for MAVF.

SMRI has the higher dividend yield at 0.86%, compared with 0.37% for MAVF.

They also come from different issuers: Matrix and Bushido. Their fees differ too: 0.75% for MAVF and 0.71% for SMRI.

SMRI currently has the higher Sharpe Ratio (2.64 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MAVF and SMRI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer